Showing results (2111-2120 of 2,132) with videos related to

Sort By:
Pageof 214
Nature Communications|February 23, 2024
Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatientsJoseph F Standing, Laura Buggiotti, Jose Afonso Guerra-Assuncao, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 6, 2025
Utility of genome sequencing and group-enrichment to support splice variant interpretation in Marfan syndromeSusan Walker, David J Bunyan, Huw B Thomas, et al.
Physical Review Letters|March 7, 2025
First Measurement of the Neutron-Emission Probability with a Surrogate Reaction in Inverse Kinematics at a Heavy-Ion Storage RingM Sguazzin, B Jurado, J Pibernat, et al.
Npj Biodiversity|February 25, 2026
A global biodiversity use data infrastructure acknowledging indigenous and local knowledgeCristiane Julião Pankararu, Irene Teixidor-Toneu, Guillaume Odonne, et al.
The Journal of Cardiovascular Surgery|April 6, 2013
BRAVISSIMO: 12-month results from a large scale prospective trialM Bosiers, K Deloose, J Callaert, et al.
Analytical Chemistry|November 6, 2013
Development of a Standard Reference Material for metabolomics researchKaren W Phinney, Guillaume Ballihaut, Mary Bedner, et al.
Physical Review Letters|April 2, 2019
Approaching the Gamow Window with Stored Ions: Direct Measurement of ^{124}Xe(p,γ) in the ESR Storage RingJ Glorius, C Langer, Z Slavkovská, et al.
Lancet (London, England)|December 25, 2022
Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trialChristopher C Butler, F D Richard Hobbs, Oghenekome A Gbinigie, et al.
Chest|July 5, 2022
Neutralizing COVID-19 Convalescent Plasma in Adults Hospitalized With COVID-19: A Blinded, Randomized, Placebo-Controlled TrialWesley H Self, Allison P Wheeler, Thomas G Stewart, et al.
Nature Genetics|March 30, 2026
Biallelic variants in RNU2-2 cause a remarkably frequent developmental and epileptic encephalopathyAdam Jackson, Alexander J M Blakes, Bader Alhaddad, et al.
Pageof 214